EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The emerging role of CARM1 in cancer

Zizhuo Xie, Yuan Tian, Xiaohan Guo, Na Xie

Cellular Oncology · 2024-10 · 47 (5) · 1503-1522

DOI: 10.1007/s13402-024-00943-9 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cellular Oncology, online erschienen am 15.04.2024. Verfasst von Zizhuo Xie und 3 weiteren Autor:innen. Beteiligte Einrichtung: West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, 6…. Hauptthemen laut MEDLINE: Protein-Arginine N-Methyltransferases, Neoplasms. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coactivator-associated arginine methyltransferase 1 (CARM1), pivotal for catalyzing arginine methylation of histone and non-histone proteins, plays a crucial role in developing various cancers. CARM1 was initially recognized as a transcriptional coregulator by orchestrating chromatin remodeling, transcription regulation, mRNA splicing and stability. This diverse functionality contributes to the recruitment of transcription factors that foster malignancies. Going beyond its established involvement in transcriptional control, CARM1-mediated methylation influences a spectrum of biological processes, including the cell cycle, metabolism, autophagy, redox homeostasis, and inflammation. By manipulating these physiological functions, CARM1 becomes essential in critical processes such as tumorigenesis, metastasis, and therapeutic resistance. Consequently, it emerges as a viable target for therapeutic intervention and a possible biomarker for medication response in specific cancer types. This review provides a comprehensive exploration of the various physiological functions of CARM1 in the context of cancer. Furthermore, we discuss potential CARM1-targeting pharmaceutical interventions for cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein-Arginine N-MethyltransferasesNeoplasmsHumansAnimalsGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

Arginine methylationBiomarkerCARM1Therapeutic targetTumorigenesis

Substanzen

Protein-Arginine N-Methyltransferasescoactivator-associated arginine methyltransferase 1

Autor:innen und Institutionen

  • West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, China.
  • West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, China. naxie@scu.edu.cn.

Zitieren

APA

Xie, Z., Tian, Y., Guo, X., & Xie, N. (2024). The emerging role of CARM1 in cancer. Cellular Oncology, 47(5), 1503-1522. https://doi.org/10.1007/s13402-024-00943-9

Vancouver

Xie Z, Tian Y, Guo X, Xie N. The emerging role of CARM1 in cancer. Cellular Oncology. 2024;47(5):1503-1522. doi:10.1007/s13402-024-00943-9

BibTeX
@article{Xie2024,
  author = {Xie, Zizhuo and Tian, Yuan and Guo, Xiaohan and Xie, Na},
  title = {The emerging role of CARM1 in cancer},
  journal = {Cellular Oncology},
  year = {2024},
  volume = {47},
  number = {5},
  pages = {1503--1522},
  doi = {10.1007/s13402-024-00943-9}
}
Kostenlos starten →